Latest Integration News

Clarity Pharmaceuticals reports robust progress in prostate cancer and neuroendocrine tumour trials alongside a strong cash position of $226.2 million, underpinning its path towards commercialisation.

Raptor Metals Ltd has completed its takeover of Raptor Resources Limited, marking a strategic pivot to copper exploration in Canada’s Bathurst Mining Camp, backed by a fresh A$5 million capital raise.

Lord Resources has reported final assay results from its maiden drilling at the Ilgarari Copper Project, revealing significant high-grade copper extensions and refining its geological model.

Larvotto Resources is on track for mid-2026 production at its Hillgrove Antimony-Gold Project, backed by robust drilling results, plant refurbishment progress, and promising tungsten recovery. The company also expands its copper portfolio with a strategic option on the Blockade Mine in Mt Isa.

IMEXHS Limited has reported a strong finish to FY25, delivering revenue and underlying EBITDA at the top end of its guidance, driven by robust software growth and expanding recurring revenue.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

4DMedical has secured a commercial contract with University of Chicago Medicine to deploy its CT, VQ™ lung imaging technology, marking the fifth major US academic medical centre to adopt the platform since FDA clearance.

HITIQ has made significant strides in expanding its concussion management technology, PROTEQT©, into North America and Australian retail, backed by strong research partnerships and a successful capital raise.

AuMEGA Metals has advanced its exploration portfolio in Newfoundland with the Isle aux Morts Granite emerging as a prime target and new gold trends identified at Bunker Hill. Diamond drilling results from Cape Ray are eagerly awaited.

IPB Petroleum is set to expand its footprint into Alaska’s National Petroleum Reserve with a major lease acquisition, supported by a recent $1.27 million capital raise. The company also plans a rebrand to Forte Energy, signalling a new chapter.

4DMedical has rapidly commercialised its CT – VQ™ lung imaging technology following FDA clearance, securing major partnerships and regulatory approvals that position it for significant growth in North America.

Cann Group Limited has reported its first-ever free cash flow positive quarter, following a significant debt restructuring and a $9 million capital raise. Despite a softer quarterly revenue, the company is advancing new product launches and export partnerships, positioning itself for growth.